Figure S4 from Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti–PD-1 Immunotherapy
Authors:
- Sana M. ArnoukSASana M. Arnouk
- Daliya KanchevaDKDaliya Kancheva
- Helena Van DammeHDHelena Van Damme
- Guillaume E. CourtoyGuillaume E. Courtoy
- Romina Mora BarthelmessRBRomina Mora Barthelmess
- Jolien Van CraenenbroeckJCJolien Van Craenenbroeck
- Els LebeggeELEls Lebegge
- Yvon ElkrimYEYvon Elkrim
- Naela AssafNANaela Assaf
- Yves HeremansYHYves Heremans
- Aleksandar MurgaskiAMAleksandar Murgaski
- Timo W.M. De GroofTimo W.M. De Groof
Open Access
- 1 December 2025
- other
- Published by American Association for Cancer Research (AACR)